8th Annual Quality & OPEX in Pharma & Biotech
Venue: Le Méridien Parkhotel
|Event Date/Time: Oct 04, 2012|
Amer Alghabban, Global Director of Audit Management, will speak about Hosting FDA and EU regulatory authority inspections. By reading between the lines, he will explain the legal frameworks and reasons of inspections. Practical advice will also be a part of his presentation. Do you know how to prepare for the inspection? What are the main dos and donâ€™ts during inspection and what happens after?
Emiliano Toso, Molecular Biology Head, will help you solve the dilemma Molecular biology for biopharma and quality control: Danger tool or perfect solution? In his case study he will introduce the new perception of using molecular biology and PCR based testing methods, and explain how facility design, GMP compliance and highly trained personnel really makes the difference.
Leading pharma players understand that manufacturing quality is increasingly a key driver in successful and timely product launches, optimizing revenue streams, enhancing the companyâ€™s reputation and maximizing shareholder value.
How successful are you in taking proactive approaches to managing quality risks & facilitating continual improvement in operational excellence?
THIS MEETING WILL EMBRACE THE WHOLE PHARMA QUALITY PROCESS AND DELIVER YOU THE KEY INSIGHTS ON:
How to link quality to performance and business strategy
Achieving quality-operational excellence synergies
Deploying quality risk management tools & techniques
Regulatory insight on achieving the highest compliance with quality standards
Lean thinking in manufacturing and across the entire organization
QbD & PAT, six sigma, Kaizen approach and other new concepts to achieve process improvements in pharma and biotech
Facilitating continuous improvement in quality & OPEX